[1]
Bednarek, I. et al. 2025. Emicizumab in the Treatment of Hemophilia A. Characteristics and clinical application. Journal of Education, Health and Sport. 81, (Nov. 2025), 66759. DOI:https://doi.org/10.12775/JEHS.2025.81.66759.